These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9574920)

  • 1. Implications of mycoplasma contamination in Plasmodium falciparum cultures and methods for its detection and eradication.
    Rowe JA; Scragg IG; Kwiatkowski D; Ferguson DJ; Carucci DJ; Newbold CI
    Mol Biochem Parasitol; 1998 Apr; 92(1):177-80. PubMed ID: 9574920
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment and control of mycoplasma contamination in Plasmodium falciparum culture.
    Singh S; Puri SK; Srivastava K
    Parasitol Res; 2008 Dec; 104(1):181-4. PubMed ID: 18825414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics.
    Uphoff CC; Meyer C; Drexler HG
    Leukemia; 2002 Feb; 16(2):284-8. PubMed ID: 11840296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of mycoplasma contamination in cell lines with enrofloxacin (Baytril).
    Fleckenstein E; Uphoff CC; Drexler HG
    Leukemia; 1994 Aug; 8(8):1424-34. PubMed ID: 7520103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone resistance in Mycoplasma gallisepticum: DNA gyrase as primary target of enrofloxacin and impact of mutations in topoisomerases on resistance level.
    Reinhardt AK; Kempf I; Kobisch M; Gautier-Bouchardon AV
    J Antimicrob Chemother; 2002 Oct; 50(4):589-92. PubMed ID: 12356806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of mycoplasmas to a new quinolone, BAY Y 3118.
    Renaudin H; Bébéar C
    Drugs; 1995; 49 Suppl 2():243-5. PubMed ID: 8549318
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
    Pereyre S; Renaudin H; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3165-8. PubMed ID: 15273141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparfloxacin and other new fluoroquinolones.
    Richard P; Gutmann L
    J Antimicrob Chemother; 1992 Dec; 30(6):739-44. PubMed ID: 1337749
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycoplasma contamination in cell culture.
    Wasserman M
    Am Biotechnol Lab; 1993 Jan; 11(1):10-2. PubMed ID: 7678745
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of mycoplasma contamination in in vitro culture of Plasmodium falciparum without antibiotic treatment - a preliminary report.
    Agarwal P; Srivastava RK; Puri SK; Srivastava K
    Res Microbiol; 2013 Apr; 164(3):211-5. PubMed ID: 23277231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of mycoplasma contaminations.
    Uphoff CC; Drexler HG
    Methods Mol Biol; 2005; 290():25-34. PubMed ID: 15361653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of mycoplasma contaminations.
    Uphoff CC; Drexler HG
    Methods Mol Biol; 2013; 946():15-26. PubMed ID: 23179823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles of mycoplasmas and development of resistance to quinolones in bacteria.
    Medvedeva ES; Baranova NB; Mouzykantov AA; Grigoreva TY; Davydova MN; Chernova OA; Chernov VM
    Dokl Biochem Biophys; 2014 Jan; 454(1):34-7. PubMed ID: 24633610
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of alcohol on growth of Plasmodium falciparum.
    Lell B; Binh VQ; Kremsner PG
    Wien Klin Wochenschr; 2000 May; 112(10):451-2. PubMed ID: 10890137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment.
    Deguchi T; Maeda S; Tamaki M; Yoshida T; Ishiko H; Ito M; Yokoi S; Takahashi Y; Ishihara S
    J Antimicrob Chemother; 2001 Nov; 48(5):742-4. PubMed ID: 11679571
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human tumour necrosis factor is not inhibitory to Plasmodium falciparum in vitro.
    Hviid L; Reimert CM; Theander TG; Jepsen S; Bendtzen K
    Trans R Soc Trop Med Hyg; 1988; 82(1):48-9. PubMed ID: 3140445
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.
    Wang C; Ewing M; Aarabi SY
    Avian Dis; 2001; 45(2):456-60. PubMed ID: 11417828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
    Duffy LB; Crabb D; Searcey K; Kempf MC
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
    Jordan FT; Forrester CA; Ripley PH; Burch DG
    Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Mycoplasma hyosynoviae and M. hyorhinis to antimicrobial agents.
    Kobayashi H; Sonmez N; Morozumi T; Mitani K; Ito N; Shiono H; Yamamoto K
    J Vet Med Sci; 1996 Nov; 58(11):1107-11. PubMed ID: 8959659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.